Jeroen van den Akker

ORCID: 0000-0002-3071-3410
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Genomics and Diagnostics
  • Genomics and Rare Diseases
  • Blood properties and coagulation
  • BRCA gene mutations in cancer
  • Breast Cancer Treatment Studies
  • Gene expression and cancer classification
  • Genetic factors in colorectal cancer
  • HER2/EGFR in Cancer Research
  • COVID-19 Clinical Research Studies
  • 3D Printing in Biomedical Research
  • Nutrition, Genetics, and Disease
  • Collagen: Extraction and Characterization
  • Cellular Mechanics and Interactions
  • Genomic variations and chromosomal abnormalities
  • Diagnosis and Treatment of Venous Diseases
  • Genetics, Bioinformatics, and Biomedical Research
  • Platelet Disorders and Treatments
  • Molecular Biology Techniques and Applications
  • Biomedical Text Mining and Ontologies
  • Protease and Inhibitor Mechanisms
  • Advanced Breast Cancer Therapies
  • Rheology and Fluid Dynamics Studies
  • Single-cell and spatial transcriptomics
  • Nitric Oxide and Endothelin Effects
  • Helicobacter pylori-related gastroenterology studies

Erasmus University Rotterdam
2025

Erasmus MC
2025

University Medical Center Utrecht
2022

Color (United States)
2017-2020

Agendia (Netherlands)
2012-2020

University of Amsterdam
2008-2012

European Organisation for Research and Treatment of Cancer
2012

Champalimaud Foundation
2012

UC Davis Comprehensive Cancer Center
2012

Institut Català d'Oncologia
2012

Recent advancements in next-generation sequencing have greatly expanded the use of multi-gene panel testing for hereditary cancer risk. Although genetic helps guide clinical diagnosis and management, recommendations are based on personal family history ethnicity, many carriers being missed. Herein, we report results from 23,179 individuals who were referred 30-gene risk, independent current guidelines-38.7% would not met National Comprehensive Cancer Network criteria testing. We identified a...

10.1016/j.jmoldx.2019.03.001 article EN cc-by-nc-nd Journal of Molecular Diagnostics 2019-06-11

Many women with an elevated risk of hereditary breast and ovarian cancer have previously tested negative for pathogenic mutations in BRCA1 BRCA2. Among them, a subset has susceptibility to requires further testing. We sought identify specific groups who remain at high evaluate whether they should be offered multi-gene panel 300 on were enrolled long-term study UCSF. As part their care, all BRCA2 either by limited or comprehensive sequencing. Additionally, met one the following criteria: (i)...

10.1007/s10549-017-4181-0 article EN cc-by Breast Cancer Research and Treatment 2017-03-09

While inward remodeling of small arteries in response to low blood flow, hypertension, and chronic vasoconstriction depends on type 2 transglutaminase (TG2), the mechanisms action have remained unresolved. We studied regulation TG2 activity, its (sub) cellular localization, substrates, specific mode during artery remodeling. found that isolated mouse mesenteric by exogenous required presence a reducing agent. The effect depended cross-linking as indicated lack mutant TG2. cell-permeable...

10.1371/journal.pone.0023067 article EN cc-by PLoS ONE 2011-08-25

Advances in genome sequencing have led to a tremendous increase the discovery of novel missense variants, but evidence for determining clinical significance can be limited or conflicting. Here, we present Learning from Evidence Assess Pathogenicity (LEAP), machine learning model that utilizes variety feature categories classify and achieves high performance multiple genes different health conditions. Feature include functional predictions, splice population frequencies, conservation scores,...

10.1002/humu.24011 article EN cc-by-nc-nd Human Mutation 2020-03-16
Linda Nab Chantal Visser Bas C. T. van Bussel Albertus Beishuizen Remy H.H. Bemelmans and 95 more Hugo Ten Cate F. Nanne Croles Coen van Guldener Cornelis P. C. de Jager Menno V. Huisman Marten R. Nijziel Pieter W. Kamphuisen Frederikus A. Klok Stefanie Koster Nuray Kuşadasi Karina Meijer Corstiaan A. den Uil Roger E. G. Schutgens Frank Stam Alexander P. J. Vlaar Eline A. Vlot Marijke Linschoten Folkert W. Asselbergs Marieke J.H.A. Kruip Saskia le Cessie Suzanne C. Cannegieter Jeroen van den Akker Amein K. Al‐Ali Fahd A Al-Muhanna N. Y. Y. Al-Windy Y. A. Almubarak A. N. Alnafie Mohammed Alshahrani A. M. Alshehri R. L. Anthonio M. Louisa Antoni Avinash Aujayeb Diederik van de Beek Jan Berg Tom W. van de Berg Ruben Bierings Maartje van den Biggelaar Wim Boersma Bram van den Borst Mettine H.A. Bos Firdaouss Boutkourt A. J. M. van Boxem Rolf E. Brouwer Matthijs C. Brouwer Richard Bruggeman J. Burggraaf Sytze de Bruin Gaby Captur Massimo Caputo Arina J. ten Cate‐Hoek N. Charlotte Michiel Coppens Annie Cornet Olaf L. Cremer Paul Dark Johan De Sutter C. E. Delsing H. G. R. Dorman J. T. Drost Renée A. Douma Jeroen Eikenboom Jacobien Ellerbroek Mireille E. Emans Henrik Endeman Nick van Es Paul L. den Exter Harald J. Faber Joyce Faber Laura M. Faber Janise Braga Barros Ferreira Barbara Festen Bas Franken Laurence Gabriël Wiek H. van Gilst J.J. Miranda Geelhoed Geert-Jan Geersing Marco Goeijenbier Diederik Gommers Eric C. M. Van Gorp B. E. Groenemeijer Marco J.J.H. Grootenboers Lianne R. de Haan Thijs F. van Haaps Tilman M. Hackeng H. E. Haerkens-Arends Gideon R. Hajer Pim van der Harst Behnam Hedayat Dirk J. van der Heijden Elias Hellou Yvonne Henskens Lisa Hessels R. S. Hermanides J.F. Hermans-van Ast Cees M.P.M. Hertogh

Thrombotic complications are common in Coronavirus disease 2019 (COVID-19) patients, with pulmonary embolism (PE) being the most frequent. Randomised trials have provided inconclusive results on optimal dosage of thromboprophylaxis critically ill COVID-19 patients. We utilized data from multicentre CAPACITY-COVID patient registry to assess effect differential application Low Molecular Weight Heparin (LMWH) dose protocols PE and in-hospital mortality risk An instrumental variable analysis was...

10.1038/s41598-024-77858-w article EN cc-by-nc-nd Scientific Reports 2025-03-25

Transglutaminase 2 (TG2) is a pleiotropic enzyme involved in both intra- and extracellular processes. In the matrix, TG2 stabilizes matrix by covalent cross-linking disulfide isomerase activity. These functions become especially apparent during remodeling as seen wound healing, tumor development vascular remodeling. However, lacks signal sequence for classical secretory mechanism, cellular mechanism of secretion currently unknown. We developed green fluorescent fusion protein to study...

10.1007/s00726-011-1010-3 article EN cc-by-nc Amino Acids 2011-08-09

Next generation sequencing (NGS) has become a common technology for clinical genetic tests. The quality of NGS calls varies widely and is influenced by features like reference sequence characteristics, read depth, mapping accuracy. With recent advances in software tools, the majority variants called using alone are fact accurate reliable. However, small subset difficult-to-call that still do require orthogonal confirmation exist. For this reason, many laboratories confirm results...

10.1186/s12864-018-4659-0 article EN cc-by BMC Genomics 2018-04-17
Tessa Noordermeer Roger E. G. Schutgens Chantal Visser Emma Rademaker Moniek P.M. de Maat and 95 more A.J. Gerard Jansen Maarten Limper Olaf L. Cremer Marieke J. H. A. Kruip Henrik Endeman Coen Maas Bas de Laat Rolf T. Urbanus Diederik van de Beek Matthijs C. Brouwer Sanne de Bruin Michiel Coppens Nick van Es T.F. van Haaps Nicole P. Juffermans Mogens Müller Alexander P. J. Vlaar Cees M.P.M. Hertogh Leo Heunks Jacqueline G. Hugtenburg Janine van Kooten Esther J. Nossent Yvo M. Smulders P.R. Tuinman Anton Vonk Noordegraaf Marco J.J.H. Grootenboers Coen van Guldener Matthias Kant A. Lansbergen Joyce Faber G.F. Hajer A. Stemerdink Jeroen van den Akker Ruben Bierings Henrik Endeman Marco Goeijenbier Nicole Hunfeld Eric C. M. Van Gorp Diederik Gommers Marion Koopmans Marieke J.H.A. Kruip Todd Kuiken Thomas Langerak Leebeek Mandy N. Lauw Moniek P.M. de Maat Danny Noack Marthe S. Paats Matthijs P. Raadsen Barry Rockx Casper Rokx Carolina A. M. Schurink Kirby Tong‐Minh Leon van den Toorn Corstiaan A. den Uil Chantal Visser Firdaouss Boutkourt Thirza J. Roest Renée A. Douma Lianne R. de Haan M. ten Wolde Remy H.H. Bemelmans Barbara Festen Susanne Stads Cornelis P. C. de Jager Koen S. Simons M. Louisa Antoni Mettine H.A. Bos J. Burggraaf Suzanne C. Cannegieter Jeroen Eikenboom P.L. den Exter J.J. Miranda Geelhoed M.V. Huisman Evert de Jonge Fleur H.J. Kaptein Frederikus A. Klok Lucia J.M. Kroft Willem M. Lijfering Linda Nab M.K. Ninaber Hein Putter S.R.S. Ramai Andres Rondon Anna H.E. Roukens Milou A.M. Stals Henri H. Versteeg Hubert W. Vliegen B.J.M. van Vlijmen Tove Berg Rainer Brüggemann Bas C. T. van Bussel Hugo Ten Cate Arina J. ten Cate‐Hoek Tilman M. Hackeng

Thrombosis is a frequent and severe complication in patients with coronavirus disease 2019 (COVID-19) admitted to the intensive care unit (ICU). Lupus anticoagulant (LA) strong acquired risk factor for thrombosis various diseases frequently observed COVID-19. Whether LA associated COVID-19 currently unclear.To investigate if critically ill COVID-19.The presence of other antiphospholipid antibodies was assessed ICU. determined dilute Russell's viper venom time (dRVVT) LA-sensitive activated...

10.1002/rth2.12809 article EN cc-by-nc-nd Research and Practice in Thrombosis and Haemostasis 2022-08-01

While matrix remodeling plays a key role in vascular physiology and pathology, the underlying mechanisms have remained incompletely understood. We studied of collagen matrices by individual smooth muscle cells (SMCs), clusters monolayers. In addition, we focused on contribution transglutaminase 2 (TG2), which an important small arteries. Single SMCs displaced fibers at distances up to least 300 μm course 8-12 h. This process involved both 'hauling up' local compaction distance from cells,...

10.1007/s11517-012-0916-6 article EN cc-by Medical & Biological Engineering & Computing 2012-06-07

Gene expression data obtained in large studies hold great promises for discovering disease signatures or subtypes through analysis. It is also prone to technical variation, whose removal essential avoid spurious discoveries. Because this variation not always known and can be confounded with biological signals, its a challenging task. Here we provide step-wise procedure comprehensive analysis of the MINDACT microarray dataset. The trial enrolled 6693 breast cancer patients prospectively...

10.1038/s42003-020-1111-1 article EN cc-by Communications Biology 2020-07-27

384 Background: Between 25 and 35% of stage II colon cancer patients will experience a relapse their disease may benefit from adjuvant chemotherapy. ColoPrint is gene expression classifier that can predict in with early-stage colorectal (Salazar et al. JCO 2011). Methods: was developed using data whole genome microarrays validated in-silico datasets independent patient cohorts 5 European hospitals. Fresh frozen tissues, clinical parameters, MSI-status follow-up for were available. Samples...

10.1200/jco.2012.30.4_suppl.384 article EN Journal of Clinical Oncology 2012-02-01

Abstract Background Biology has become the main driver of breast cancer (BC) therapy. Biological subtypes have been recommended as a guide for treatment selection. Molecularly identified can be determined by gene expression profiling. Alternatively, pathology used to define surrogates these subtypes. These methodologies are not always concordant, which lead different systemic therapies. The purpose this preplanned translational research is investigate concordance between molecular based...

10.1158/1538-7445.sabcs14-p4-11-08 article EN Cancer Research 2015-05-01

The relevance of large copy number variants (CNVs) to hereditary disorders has been long recognized, and population sequencing efforts have chronicled many common structural (SVs). However, limited data are available on the clinical contribution rare germline SVs. Here, a detailed characterization SVs identified using targeted next-generation was performed. Across 50 genes associated with cancer cardiovascular disorders, minimum 828 unique were reported, including 584 fully characterized...

10.1016/j.jmoldx.2021.01.015 article EN cc-by-nc-nd Journal of Molecular Diagnostics 2021-02-21

1022 Background: Biology has become the main driver of breast cancer therapy. Intrinsic biological subtypes by gene expression profiling have been identified. Pathology can be used to define surrogates these but are not always concordant, which may lead different treatment plans. We investigated concordance between BluePrint (BP) + MammaPrint (MP) (micro array based) and pathological (based on ER, PR, HER2, Ki67). Contrary Perou set (evolved into PAM50), was trained using data. Methods:...

10.1200/jco.2012.30.15_suppl.1022 article EN Journal of Clinical Oncology 2012-05-20

Microvascular remodeling is known to depend on cellular interactions with matrix tissue. However, it difficult study the role of specific cells or elements in an vivo setting. The aim this develop automated technique that can be employed obtain and analyze local collagen by single smooth muscle cells. We combined a motorized microscopic setup time-lapse video microscopy new cross-correlation based image analysis algorithm enable recording cell-induced reorganization. This method rendered...

10.1007/s11517-008-0325-z article EN cc-by-nc Medical & Biological Engineering & Computing 2008-03-06

Abstract Background: Biology has become the main driver of breast cancer therapy. Intrinsic biological subtypes by gene expression profiling have been identified. Pathology can be used to define surrogates these but are not always concordant, which may lead different treatment plans. We investigated concordance between BluePrint and MammaPrint (microarray-based) pathological (based on ER, PR, HER2 & Ki67). Methods: Using available data (centrally assessed pathology genomics) from MINDACT...

10.1158/0008-5472.sabcs12-p3-05-02 article EN Cancer Research 2012-12-01

Inward remodeling of small arteries in response to low blood flow and hypertension depends on type 2 transglutaminase (TG2). We studied the regulation TG2 activity, its localization substrates during remodeling. Isolated mouse mesenteric exposed exogenous required a reducing agent induce inward The effect depended cross-linking as indicated by lack mutant TG2. cell-impermeable TCEP did not However, cell-permeable DTT induced translocation endogenous activity at smooth muscle membrane. This...

10.1096/fasebj.25.1_supplement.1093.2 article EN The FASEB Journal 2011-04-01

Transglutaminase 2 (TG2) is known to be important for both cross‐linking of matrix proteins as well cell adhesion, cytoskeletal organization and signaling. However, its cellular distribution mechanisms secretion activation during remodeling remain unclear. We tagged TG2 at the C‐terminal with eGFP. TG2/eGFP was transfected into HEK/293T cells using Effectene. Western blot in vitro activity assay showed a >100‐fold increase active TG2. No difference observed between non‐fluorescent...

10.1096/fasebj.24.1_supplement.822.1 article EN The FASEB Journal 2010-04-01
Coming Soon ...